TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- Brain Cancer Canada (BCC), Canada's only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide is proud to announce the "Emily McIntosh Brain Cancer Research Grant" of $100,000 awarded to an innovative research project led by Dr. Sheila Singh and her team at McMaster University in Hamilton, Ontario, and collaborators at the University of Ottawa.

The project titled "Dual Targeting of glioblastoma with CAR T and viral immunotherapies" builds on previous research and aims to combine two promising immune-based therapies to attack the most common malignant primary adult brain tumour: Glioblastoma. 

Glioblastoma (GBM) is the most common malignant primary adult brain tumour. The standard treatment approach today consists of maximal surgical resection followed by radiation and chemotherapy; however, tumours come back leaving very little to offer patients other than options that can provide symptom relief without hope of a cure. 

The research led by Dr. Singh and collaborators will explore two innovative techniques that will use a specialized virus that can make the glioblastoma cells raise a signal to a patient's immune system while using a second approach to train a patient's own immune system to recognize and target the cancer cells. 

"Glioblastoma remains one ...